J. R. Kalden

4.3k total citations
57 papers, 1.7k citations indexed

About

J. R. Kalden is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, J. R. Kalden has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 19 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Immunology. Recurrent topics in J. R. Kalden's work include Monoclonal and Polyclonal Antibodies Research (18 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Systemic Lupus Erythematosus Research (12 papers). J. R. Kalden is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Systemic Lupus Erythematosus Research (12 papers). J. R. Kalden collaborates with scholars based in Germany, United States and United Kingdom. J. R. Kalden's co-authors include Bernhard Manger, Gerd‐Rüdiger Burmester, Christian Antoni, Martin Gramatzki, B Jahn, J. Zacher, Thomas Winkler, David Isenberg, Paul Emery and Michael R. Ehrenstein and has published in prestigious journals such as The Journal of Immunology, Kidney International and European Heart Journal.

In The Last Decade

J. R. Kalden

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. R. Kalden Germany 19 964 732 356 330 164 57 1.7k
M Schattenkirchner Germany 22 835 0.9× 479 0.7× 225 0.6× 316 1.0× 122 0.7× 82 1.6k
R. Aranda United States 11 1.1k 1.1× 596 0.8× 237 0.7× 527 1.6× 109 0.7× 20 1.7k
Akira Sagawa Japan 17 630 0.7× 539 0.7× 226 0.6× 121 0.4× 216 1.3× 75 1.8k
Toshihiko Hidaka Japan 21 671 0.7× 439 0.6× 118 0.3× 345 1.0× 181 1.1× 79 1.4k
Gaye Cunnane Ireland 28 1.3k 1.3× 496 0.7× 158 0.4× 361 1.1× 448 2.7× 59 2.2k
M. Lange United States 6 1.7k 1.7× 574 0.8× 261 0.7× 941 2.9× 182 1.1× 7 2.2k
Yair Molad Israel 25 959 1.0× 725 1.0× 156 0.4× 220 0.7× 415 2.5× 70 2.1k
Scott W. Baumgartner United States 16 1.4k 1.4× 766 1.0× 264 0.7× 1.0k 3.0× 343 2.1× 18 2.5k
Daniel Goldman United States 25 1.0k 1.0× 1.1k 1.5× 210 0.6× 139 0.4× 453 2.8× 64 2.1k
Elena Massarotti United States 18 697 0.7× 532 0.7× 122 0.3× 241 0.7× 152 0.9× 31 1.3k

Countries citing papers authored by J. R. Kalden

Since Specialization
Citations

This map shows the geographic impact of J. R. Kalden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. R. Kalden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. R. Kalden more than expected).

Fields of papers citing papers by J. R. Kalden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. R. Kalden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. R. Kalden. The network helps show where J. R. Kalden may publish in the future.

Co-authorship network of co-authors of J. R. Kalden

This figure shows the co-authorship network connecting the top 25 collaborators of J. R. Kalden. A scholar is included among the top collaborators of J. R. Kalden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. R. Kalden. J. R. Kalden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoels, Monika, Daniel Aletaha, J. W. J. Bijlsma, et al.. (2010). Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Annals of the Rheumatic Diseases. 69(4). 638–643. 185 indexed citations
2.
Ott, Helmut W., Verena Mattle, A. Rubbert, et al.. (2006). Treatment of hereditary angioneurotic oedema (HANE) with tibolone. Clinical Endocrinology. 66(2). 180–184. 13 indexed citations
3.
Dechant, Claudia, et al.. (2004). Langzeitergebnisse einer TNF-Blockade beim Morbus Still im Erwachsenenalter. DMW - Deutsche Medizinische Wochenschrift. 129(23). 1308–1312. 27 indexed citations
4.
Lorenz, Hannes & J. R. Kalden. (2001). Zytokin- und Anti-Zytokintherapie bei der rheumatoiden Arthritis. Der Internist. 42(1). 55–63. 1 indexed citations
5.
Keitel, W, E. Genth, Erika Gromnica‐Ihle, et al.. (2000). Guidelines for the management of joint swelling by primary care physicians. Zeitschrift für Rheumatologie. 59(3). 151–161. 4 indexed citations
6.
Witte, T, Matthias Tenbusch, H. H. Peter, et al.. (2000). IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.. PubMed. 27(11). 2617–20. 44 indexed citations
7.
Lorenz, Hanns‐Martin, Mathias Grünke, Thomas Hieronymus, et al.. (2000). In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.. PubMed. 27(2). 304–10. 19 indexed citations
8.
Kolowos, Wasilis, et al.. (1999). Biased TCR Repertoire in HIV-1-Infected Patients Due to Clonal Expansion of HIV-1-Reverse Transcriptase-Specific CTL Clones. The Journal of Immunology. 162(12). 7525–7533. 17 indexed citations
9.
Gramatzki, Martin, Wolfgang Ludwig, Renate Burger, et al.. (1998). Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.. PubMed. 26(13). 1209–14. 32 indexed citations
10.
Burkhardt, Harald & J. R. Kalden. (1997). Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases. Rheumatology International. 17(3). 85–90. 18 indexed citations
11.
Harrer, Ellen G., et al.. (1997). CD80 Expression on Monocytes in HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(4). 264–268. 3 indexed citations
12.
Herrmann, Martin, Otmar Zoller, M. Hagenhofer, Reinhard Voll, & J. R. Kalden. (1996). What triggers anti-dsDNA antibodies?. Molecular Biology Reports. 23(3-4). 265–267. 39 indexed citations
13.
Tsuzaka, Kensei, Thomas Winkler, J. R. Kalden, & Morris Reichlin. (1996). Autoantibodies to double-stranded (ds)DNA immunoprecipitate 18S ribosomal RNA by virtue of their interaction with ribosomal protein S1 and suppress in vitro protein synthesis. Clinical & Experimental Immunology. 106(3). 504–508. 7 indexed citations
14.
Kalden, J. R. & Martin Herrmann. (1993). Autoimmune Diseases in Humans, e.g. Autoimmune Rheumatic Diseases. Intervirology. 35(1-4). 176–185. 9 indexed citations
15.
Alsalameh, S, J. R. Kalden, & Gerd R Burmester. (1992). [The role of cytokines and growth factors in rheumatoid joint destruction].. PubMed. 50(6). 347–59. 3 indexed citations
16.
Harrer, Thomas, et al.. (1992). In vitroactivation of peripheral mononuclear cells by zinc in HIV-infected patients and healthy controls. Clinical & Experimental Immunology. 89(2). 285–289. 5 indexed citations
17.
Seuchter, Susanne A., Michael Knapp, Klaus Hartung, et al.. (1991). Testing for association in SLE families. Genetic Epidemiology. 8(6). 409–416. 4 indexed citations
18.
Krapf, F., et al.. (1989). Are retroviruses involved in the pathogenesis of SLE?. Rheumatology International. 9(3-5). 115–121. 17 indexed citations
19.
Burmester, Gerd‐Rüdiger, et al.. (1986). Growth frequency and stimulation of t cell clones and peripheral blood lymphocytes by supernatants of cultured synovial lining cells and synovial fluid. Immunobiology. 173. 331. 1 indexed citations
20.
Beck, PL, et al.. (1981). Autologous and allogeneic MLC-reactivity in patients with rheumatoid arthritis.. PubMed. 6(1). 27–33. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Schattenkirchner Breakdown of academic impact, for papers by R. Aranda Breakdown of academic impact, for papers by Akira Sagawa Breakdown of academic impact, for papers by Toshihiko Hidaka Breakdown of academic impact, for papers by Gaye Cunnane Breakdown of academic impact, for papers by M. Lange Breakdown of academic impact, for papers by Yair Molad Breakdown of academic impact, for papers by Scott W. Baumgartner Breakdown of academic impact, for papers by Daniel Goldman Breakdown of academic impact, for papers by Elena Massarotti
Rankless by CCL
2026